Informationes plurimae ― Latine

Urticaria vulgo papulae elevatae cum pruritu intenso attolluntur. Aliquando cum edema textuum subiectorum comitatur. Curatio imprimis implicat evitanda triggers, si notae sunt. Prima linea medicamenta antihistaminica recentiora includit, quae ad dosim superiorem, si opus fuerit, accommodari possunt. Alia medicamenta sicut antihistamina vetusta, H2 obstructores, antagonista receptoris leukotrieni, antihistaminica fortiora, et cursus breves corticosteroides adici possunt. In casibus in quibus urticaria perseveret, non obstante his rationibus, aegros ad specialistas referre possunt ad therapias additas, sicut omalizumab vel cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Haec recensio novissimas vias ad urticaria tractandas delineat et novas causas eius intellectus praebet.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids